ANI PHARMACEUTICALS INC (ANIP) › Capital ExpendituresANI PHARMACEUTICALS INC (ANIP) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2009: $165.7K2010: $63.4K2011: $719.9K2012: $292.0K2013: $191.0K2014: $1.12M2015: $2.18M2016: $4.57M2017: $10.37M2018: $5.74M2019: $6.63M2020: $6.13M2021: $2.56M2022: $8.88M2023: $8.87M2024: $16.24M2025: $13.84M$13.84M2009Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$13.84M-14.8%2024$16.24M+83.1%2023$8.87M-0.1%2022$8.88M+247.1%2021$2.56M-58.3%2020$6.13M-7.5%2019$6.63M+15.5%2018$5.74M-44.6%2017$10.37M+127.1%2016$4.57M+109.2%2015$2.18M+94.9%2014$1.12M+486.4%2013$191.0K-34.6%2012$292.0K-59.4%2011$719.9K+1034.8%2010$63.4K-61.7%2009$165.7K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share